SUSMED Competitors and Similar CompaniesClear all
SUSMED's competitors and similar companies include CEL-SCI and Upstream Bio.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1983 | Founding Date 2021 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Chuo City, JP HQ | Locations Vienna, US HQ | Locations Waltham, US HQ |
Employees | Employees 39 | Employees N/A | Employees 38 |
Valuation ($) | Valuation ($) 64.9 m | Valuation ($) 58.7 m | Valuation ($) 1.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥463m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.9m (FY, 2025) |
Cost of goods | Cost of goods ¥4.3m (FY, 2025) | Cost of goods N/A | Cost of goods $23m (FY, 2025) |
Gross profit | Gross profit ¥458.7m (FY, 2025) | Gross profit N/A | Gross profit ($20.2m) (FY, 2025) |
Net income | Net income (¥298.4m) (FY, 2025) | Net income ($25.4m) (FY, 2025) | Net income ($143.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companyUpstream Bio
HQ
Waltham, US
Employees
38
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company